The DoD just handed AeroVironment a half-billion-dollar mandate to kill drones, and the small-cap will feel every dollar of it.
The Pentagon awarded AeroVironment (AVAV) a $500 million contract for counter-drone technology, according to DefenseScoop. The award comes as drone warfare has moved from a niche concern to a central feature of modern conflict, accelerating DoD spending on both offensive and defensive unmanned systems.
Who cashes in: AeroVironment (AVAV) is the direct winner — this contract lands on a company with a roughly $5 billion market cap, so $500 million in new work is genuinely needle-moving. AVAV already makes the Switchblade loitering munition and a family of small reconnaissance drones; counter-drone systems are a natural adjacency. Kratos Defense (KTOS) is a coattail name — it builds drone targets and unmanned jet aircraft, and a DoD that is spending heavily on counter-drone also tends to spend on the threat simulators used to test those systems. Leidos (LDOS) and L3Harris (LHX) supply sensors and electronic-warfare components that feed into counter-UAS platforms and could see subcontract flow.
A $500 million contract on a $5 billion market cap is not a footnote — it's a thesis.
Who's exposed: Dedrone and other pure-play counter-drone firms are private, so there's no direct public loser here. The risk for investors is execution: AVAV has a history of cost overruns on scaled production, and a $500 million contract that slips on delivery timelines can turn a catalyst into a drag. Larger primes like Northrop Grumman (NOC) and Lockheed Martin (LMT) compete in the counter-drone space but are too big for a single $500 million award to move the needle much.
What to watch: AVAV's next earnings call for any guidance revision tied to this contract, and whether the DoD structures follow-on options that could push the total value higher. If the House 2027 defense spending bill (currently heading to the full chamber) preserves or expands counter-UAS line items, the contract could be the first tranche of a much larger program.
Source: original report ↗
Free alerts Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/mo Join the owners who run ahead of the industry. Cancel anytime, one click.